Incomplete filling of lithium heparin tubes affects the activity of creatine kinase and γ-glutamyltransferase

British Journal of Biomedical Science

Volumn 69, Issue 2, 2012, Pages 67-70

  Lippi, Giuseppe ^a   Avanzini, P ^a   Cosmai, M ^a   Aloe, R ^a   Ernst, D ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b Center for Phlebotomy Education   (United States)

Author keywords

Blood specimen collection; Creatine kinase; Heparin; Interference

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; HEPARIN; LITHIUM;

ADULT; ARTICLE; BLOOD SAMPLING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; FEMALE; HEMATOLOGICAL PROCEDURE; HUMAN; LITHIUM HEPARIN BLOOD TUBE FILLING; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL;

EID: 84865176389     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2012.12002439     Document Type: Article

References (13)

1. Plebani M, Lippi G. Closing the brain-to-brain loop in laboratory testing. Clin Chem Lab Med 2011; 49 (7): 1131-3.
2. Lippi G, Chance JJ, Church S et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011; 49 (7): 1113-26.
3. Plebani M, Lippi G. Improving the post-analytical phase. Clin Chem Lab Med 2010; 48 (4): 435-6.
4. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006; 44 (4): 358-65.
5. Ernst DJ, Ballance LO. Quality collection: the phlebotomist's role in pre-analytical errors. MLO Med Lab Obs 2006; 38 (9): 30, 32, 34 passim.
6. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med 2007; 45 (6): 720-7. (Pubitemid 46956240)
7. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost 2008; 34 (7): 612-34.
8. Clinical and Laboratory Standards Institute. Procedures for the handling and processing of blood specimens; approved guidelines 4th edn. Wayne, PA: CLSI document H18-A3, 2010.
9. Andrejat G, Fitzgibbon L, Gilis R, Rodgers J, Doumas BT. Heparin interference in creatine kinase assays. Clin Chem 1982; 28 (7): 1718-9. (Pubitemid 12090704)
10. Narayanan S. The preanalytic phase. An important component of laboratory medicine. Am J Clin Pathol 2000; 113 (3): 429-52. (Pubitemid 30217392)
11. Hørder M, Elser RC, Gerhardt W, Mathieu M, Sampson EJ. International Federation of Clinical Chemistry, Scientific Division Committee on Enzymes: approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2). Eur J Clin Chem Clin Biochem 1991; 29 (7): 435-56.
12. Ricós C, Alvarez V, Cava F et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999; 59 (7): 491-500. (Pubitemid 30056739)
13. Dimeski G, Carter A. Rare IgM interference with Roche/Hitachi Modular glucose and gamma-glutamyltransferase methods in heparin samples. Clin Chem 2005; 51 (11): 2202-4. (Pubitemid 41532652)